688767: Hangzhou Biotest Biotech Co.Ltd(688767) reply to the inquiry letter on serious abnormal fluctuation of stock trading Hangzhou Biotest Biotech Co.Ltd(688767) : the inquiry letter on serious abnormal fluctuation of stock trading Hangzhou Biotest Biotech Co.Ltd(688767) issued by your company has been received. After careful self-examination and verification, the relevant questions are replied as follows: 1. Up to now, the company has no major information that should be disclosed but not disclosed involving your company; 2、 Up to now, the company has no major events involving your company in the planning stage, including but not limited to major asset restructuring, share issuance, acquisition, debt restructuring, business restructuring, asset divestiture, asset injection, share repurchase, equity incentive, bankruptcy reorganization, major business cooperation, introduction of strategic investors and other major events
© China Stock Market News